In this context, recent reports have clearly shown the effectiveness of PD-1/PD-L1 checkpoint blockade in preventing anti-tumoral cytotoxic CD8+ T cell exhaustion [80] and counteracting the suppressive function of infiltrating Tregs leading to improved response to cancer therapy increase disease free survival [81]. The gene discussed is CD274; the disease is cancer.